#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16842	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2515	825.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1661	1661	C	1096	C	1096	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4030	885.0	0	.	n	.	0	T695C	SNP	695	695	T	1315	1315	C	1065	C,G,A	1061,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4030	885.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2258	2258	G	1123	G	1123	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4030	885.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2591	2591	C	987	C	987	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4030	885.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2665	2665	A	903	A,T,C	900,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28608	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4030	885.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3217	3217	C	1031	C,G	1030,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2278	folP	855	855	100.0	folP.l15.c17.ctg.1	1873	151.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1169	1171	AGC	232;232;230	A,G,C;G,T;C,G	230,1,1;231,1;229,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5932	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3788	195.3	1	SNP	p	S91F	1	.	.	271	273	TTC	754	756	TTC	185;184;184	T;T;C,A	185;184;183,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5932	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3788	195.3	1	SNP	p	D95G	1	.	.	283	285	GGC	766	768	GGC	189;187;184	G;G;C	189;187;184	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5932	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3788	195.3	1	SNP	p	G95N	0	.	.	283	285	GGC	766	768	GGC	189;187;184	G;G;C	189;187;184	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2142	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1615	165.0	1	SNP	p	G45D	0	.	.	133	135	GGC	654	656	GGC	253;249;250	G,T;G,T;C	252,1;248,1;250	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1228	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1325	115.2	0	.	n	.	0	A197.	DEL	197	197	A	785	785	A	227	A,C	226,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3248	217.2	1	SNP	p	D86N	0	.	.	256	258	GAC	763	765	GAC	279;281;279	G;A,G;C	279;280,1;279	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3248	217.2	1	SNP	p	R87I	0	.	.	259	261	CGT	766	768	CGT	280;277;278	C,G,A;G,A;T	278,1,1;275,2;278	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3248	217.2	1	SNP	p	R87W	0	.	.	259	261	CGT	766	768	CGT	280;277;278	C,G,A;G,A;T	278,1,1;275,2;278	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3248	217.2	1	SNP	p	S87R	1	.	.	259	261	CGT	766	768	CGT	280;277;278	C,G,A;G,A;T	278,1,1;275,2;278	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3248	217.2	1	SNP	p	S88P	0	.	.	262	264	TCC	769	771	TCC	277;275;275	T,A;C,G;C,A	276,1;274,1;274,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4750	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3022	196.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1744	1746	GGC	260;257;255	G;G;C	260;257;255	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1422	1424	GCA	294;295;293	G,T;C;A	293,1;295;293	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1425	1427	ATC	291;294;294	A;T;C	291;294;294	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1437	1439	GTG	300;300;299	G,A;T;G	299,1;300;299	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1437	1439	GTG	300;300;299	G,A;T;G	299,1;300;299	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1941	1943	ACC	259;258;258	A;C;C	259;258;258	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1995	1997	GCG	239;237;236	G,A;C,T;G	238,1;236,1;236	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1995	1997	GCG	239;237;236	G,A;C,T;G	238,1;236,1;236	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2118	2120	AGC	233;232;234	A;G;C	233;232;234	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2127	2129	GGC	236;236;236	G;G;C	236;236;236	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4564	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2730	208.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2145	2147	CCG	235;237;235	C,G;C;G,T,A	233,2;237;233,1,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6060	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3461	217.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1882	1884	CCG	260;259;260	C;C,A;G,A	260;258,1;259,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2774	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2197	157.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	774	774	C	218	C,T	217,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	13	15	TTA	23;30;32	T;T;A	23;30;32	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	58	60	CAT	66;66;66	C;A;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	61	63	AGT	66;66;66	A;G;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	70	72	TAC	66;66;66	T;A,C;C	66;65,1;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	R307E	NONSYN	919	921	AGA	160	162	GAA	4;4;4	G;A;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	172	174	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	175	177	GAC	4;4;5	G;A;C	4;4;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	181	183	ATC	5;5;5	A;T;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	187	189	TCG	5;5;5	T;C;G	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	193	195	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	196	198	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	199	201	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	340	porB1a	984	222	90.54	porB1a.l15.c17.ctg.3	301	34.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	205	207	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	T26A	NONSYN	76	78	ACC	507	509	GCC	338;339;338	G,A;C;C,A	337,1;339;336,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	543	545	GAA	314;315;311	G;A;A	314;315;311	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	954	956	TCA	321;324;325	T;C;A,G	321;324;324,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	G205S	NONSYN	613	615	GGC	1044	1046	AGC	293;291;290	A;G;C,A	293;291;289,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	D212A	NONSYN	634	636	GAT	1065	1067	GCT	284;283;291	G;C;T,A	284;283;290,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1083	1085	ATC	284;280;282	A;T,G;C,A	283;278,1;280,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	F222L	NONSYN	664	666	TTT	1095	1097	CTT	279;280;279	C;T;T	279;280;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1155	1157	GTC	297;295;296	G,T;T;C,T	296,1;295;295,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	1	SNP	p	G120K	1	.	.	358	360	AAG	789	791	AAG	289;291;290	A;A,C;G	289;290,1;290	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	1	SNP	p	A121D	1	.	.	361	363	GAC	792	794	GAC	286;282;284	G,A;A;C,A	285,1;282;283,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	98.76	porB1b.l15.c30.ctg.1	1627	255.4	1	SNP	p	D121N	0	.	.	361	363	GAC	792	794	GAC	286;282;284	G,A;A;C,A	285,1;282;283,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11172	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5246	265.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1756	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1450	151.2	1	SNP	p	V57M	1	.	.	169	171	ATG	755	757	ATG	298;300;298	A,G,C;T;G,T,C	296,1,1;300;296,1,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
